Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteria

Published Date: 01 Jul 2024

No difference in adverse events, clinical benefit, OS for patients with or without waivers

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

2.

As EGFR internalization is decreased, BUB1 controls EGFR signaling.

3.

Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation

4.

Low Income, Education Tied to Depression in Older Adults

5.

In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot